We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FIRM WAITS FOR PATENT TO LAUNCH GENERIC BIAXIN
FIRM WAITS FOR PATENT TO LAUNCH GENERIC BIAXIN
July 27, 2004
Multiple generic firms are lining up to launch versions of Abbott Laboratories’ profitable antibiotic Biaxin once the basic patent expires next May, but expected legal moves by Abbott could delay generic entry, experts say.